In a very 2004 letter towards the FDA, Purdue legal professionals claimed the company planned to continue advertising and marketing OxyContin to Physicians like a twelve-hour drug for several factors, which includes "competitive edge."They went on to create a case far unique than the one Purdue income reps were being producing to Medical practition